Back
KalVista Pharmaceuticals, Inc. Vs. MicroSectors Gold Miners -3X Inverse Leveraged ETN Industry Stock Comparison
Buy
70
KALV
KalVista Pharmaceuticals, Inc.
Last Price:
$19.91
Seasonality Move:
-0.88%
Sell
23
GDXD
MicroSectors Gold Miners -3X Inverse Leveraged ETN
Last Price:
$37.43
Seasonality Move:
6.74%
Buy
70
KalVista Pharmaceuticals, Inc. (KALV)
is a Buy
Is KalVista Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current KalVista Pharmaceuticals, Inc. [KALV] share price is $19.90. The Score for KALV is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KALV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
MicroSectors Gold Miners -3X Inverse Leveraged ETN (GDXD)
is a Sell
Is MicroSectors Gold Miners -3X Inverse Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors Gold Miners -3X Inverse Leveraged ETN [GDXD] share price is $37.37. The Score for GDXD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
GDXD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KALV Stock Price Chart
What is KalVista Pharmaceuticals, Inc.'s stock price today?
-
The KalVista Pharmaceuticals, Inc. share price today is $19.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KALV is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDXD Stock Price Chart
What is MicroSectors Gold Miners -3X Inverse Leveraged ETN's stock price today?
-
The MicroSectors Gold Miners -3X Inverse Leveraged ETN share price today is $37.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDXD is experiencing selling pressure, which indicates risk of future bearish movement.
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 64.89 | Buy |
| Chaikin Money Flow: | 462350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.01 - 18.71) | Buy |
| Bollinger Bands (100): | (14.03 - 17.29) | Buy |
GDXD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 43.04 | Sell |
| Chaikin Money Flow: | -1163800 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.34 - 54.86) | Sell |
| Bollinger Bands (100): | (32.7 - 108.48) | Sell |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.76 | Buy |
| 20-day SMA: | 17.67 | Buy |
| 50-day SMA: | 16.39 | Buy |
| 200-day SMA: | 14.3 | Buy |
| 8-day EMA: | 18.94 | Buy |
| 20-day EMA: | 17.87 | Buy |
| 50-day EMA: | 16.76 | Buy |
| 200-day EMA: | 14.61 | Buy |
GDXD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.88 | Sell |
| 20-day SMA: | 46.57 | Sell |
| 50-day SMA: | 41.41 | Sell |
| 200-day SMA: | 221.25 | Sell |
| 8-day EMA: | 45.44 | Sell |
| 20-day EMA: | 45.91 | Sell |
| 50-day EMA: | 51.36 | Sell |
| 200-day EMA: | 424.58 | Sell |
KalVista Pharmaceuticals, Inc. Earnings Growth & KALV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $2.01 per share.
MicroSectors Gold Miners -3X Inverse Leveraged ETN Earnings Growth & GDXD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MicroSectors Gold Miners -3X Inverse Leveraged ETN Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||